Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Appointed director
CC transcript
Asset disposition
Quarterly results
Appointed CFO
ImmunoGen, Inc. (IMGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/25/2023 144 Form 144 - Report of proposed sale of securities:
08/24/2023 144 Form 144 - Report of proposed sale of securities:
08/23/2023 144 Form 144 - Report of proposed sale of securities:
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/18/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 144 Form 144 - Report of proposed sale of securities:
08/04/2023 144 Form 144 - Report of proposed sale of securities:
08/04/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 144 Form 144 - Report of proposed sale of securities:
07/31/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/31/2023 8-K Quarterly results
06/16/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Amended and Restated By-Laws, marked for amendments"
05/05/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement",
"Letter re: Registration Statement on Form S-3",
"PART II INFORMATION NOT REQUIRED IN PROSPECTUS Item 14. Other Expenses of Issuance and Distribution."
05/05/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/05/2023 144 Form 144 - Report of proposed sale of securities:
05/03/2023 8-K Quarterly results
05/02/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "Articles of Amendment",
"Exchange Agreement, by and among ImmunoGen, Inc. and RA Capital Healthcare Fund, L.P"
04/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
04/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
04/28/2023 8-K Quarterly results
04/26/2023 ARS Form ARS - Annual Report to Security Holders:
04/26/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/06/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "ImmunoGen Announces Non-Dilutive Term Loan Financing for Up to"
03/01/2023 10-K Annual Report for the period ended December 31, 2022
03/01/2023 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy